
Official account for CAPA (全美华人病理学会). Supporting Chinese American #pathologists in the United States and Canada. RTs/Follows ≠ endorsements.
Austin, TX
Joined September 2022
- Tweets600
- Following753
- Followers1.2K
- Likes1.5K
Who we are: CAPA is a non-for-profit organization of the Chinese American #pathologists in US and Canada who are in practice or training. Since its establishment in 2004, CAPA has developed as a nationally and internationally recognized organization with over 830 members today.
Digital pathology from glass slide, whole-slide image to AI and beyond. Join #CAPA Oct 11 (Sun) 7PM ET as Dr. Limin Yu presents “Fundamental of Digital Pathology,” covering WSI workflow, image quality, validation, implementation, and emerging clinical AI. #PathTwitter
What do you do when breast cancer biomarkers don’t look quite right? Join #CAPA OLE breast lecture on Oct 4 (Sun) at 7PM ET as Dr. Huina Zhang discusses unusual biomarker results, common pitfalls, and practical approaches to accurate evaluation. #PathTwitter #BreastPath
What makes a satisfying and sustainable career in pathology? Join #CAPA on Sept 26 (Sat) 7-8PM ET as Dr. John D. Cochran shares “Career Satisfaction and Advancement in Pathology.” Practical perspectives on career planning, asking the right questions, and navigating the path ahead
Coming this Sunday! Don’t miss it.
The digital transformation of pathology is moving fast. Join #CAPA on Sept 27 (Sun) at 7PM ET for a special symposium with Hologic featuring Dr. Matthew G. Hanna, with insights into digital diagnostic system, implementation, and real-world clinical experience. #PathTwitter
Chinese American Pathologists Association retweeted
The digital transformation of pathology is moving fast. Join #CAPA on Sept 27 (Sun) at 7PM ET for a special symposium with Hologic featuring Dr. Matthew G. Hanna, with insights into digital diagnostic system, implementation, and real-world clinical experience. #PathTwitter
CK5/6, S100, p63, CD34– how do you use them in daily breast pathology practice? Join #CAPA Sept 20 (Sun) 7PM ET as Drs. Ping Tang & Xiuzhen Duan discuss the diagnostic applications and limitations of these commonly used IHC markers. #PathTwitter #BreastPath
The digital transformation of pathology is moving fast. Join #CAPA on Sept 27 (Sun) at 7PM ET for a special symposium with Hologic featuring Dr. Matthew G. Hanna, with insights into digital diagnostic system, implementation, and real-world clinical experience. #PathTwitter
The 12th Annual CAPA Diagnostic Course starts today in Flushing, NY! 🎉 With beautiful weather to welcome everyone, we’re looking forward to two days of pathology education, career development, and networking. Great to see colleagues and friends gathering again! #PathTwitter
Three pathologists; different career paths; shared lessons for the next generation. Join #CAPA on Sept 12, 12:05–1PM ET for a panel with Drs. Lirong Cheng, Peter Wang & Peng Ji (@PengJi_lab) on strategic planning for early-career milestones. #PathTwitter
Challenging breast cases often come down to the right clues. Join #CAPA on Aug 23 (Sun) 7PM ET as Dr. Hongxia Sun discusses diagnostic pitfalls, key morphologic and IHC findings, and practical approaches to difficult cases. #PathTwitter #BreastPath
From papilloma to papillary carcinoma, breast papillary lesions span a challenging diagnostic spectrum. Join #CAPA #BreastPath Lectures Aug 16 (Sun) 7PM ET as Dr. Jing He shares a practical approach to morphology, IHC, and core biopsy interpretation. #PathTwitter
Happening today! Don’t miss it.
We’re proud to launch CAPA Grand Rounds with an inaugural lecture by Dr. Syed Z. Ali from @JHUPath. Join us on Aug 13 (Thu), 12 PM ET, for “The Bethesda Thyroid Revolution: Impact, Challenges, and Future Directions.” Don’t miss this timely update on thyroid #CytoPath #PathTwitter
Kick off a weekend of #CAPA learning! Join us Aug 8 (Sat) 7 PM ET as Dr. Sinchita Roy-Chowdhuri shares “My Academic Career in Pathology.” Explore different academic career paths, finding your strengths, and why learning when to say “no” can open new doors. #PathTwitter
🔬The #CAPA Breast Lecture Series continues! Join us Aug 9 (Sun) 7PM ET as Dr. Di “Andy” Ai presents “Invasive Lobular Carcinoma: Core Concepts and Emerging Updates.” A focused discussion on histologic spectrum, E-cadherin/p120 biology, and diagnostic challenges. #PathTwitter
📅 Just over a week to go! Join us for the inaugural CAPA Grand Rounds featuring Dr. Syed Z. Ali, who will discuss the evolution of the Bethesda Thyroid Reporting System and its impact on modern thyroid cytopathology. We look forward to seeing you on Aug. 13! #PathTwitter
We’re proud to launch CAPA Grand Rounds with an inaugural lecture by Dr. Syed Z. Ali from @JHUPath. Join us on Aug 13 (Thu), 12 PM ET, for “The Bethesda Thyroid Revolution: Impact, Challenges, and Future Directions.” Don’t miss this timely update on thyroid #CytoPath #PathTwitter
A new lecture series begins! Join the inaugural #CAPA Breast Lecture Series on Aug 2 (Sun), 7 PM ET. Dr. Yanjun Hou will share a practical approach to fibroepithelial lesions of the breast, including fibroadenomas, phyllodes tumors, and challenging core biopsies. #PathTwitter
Join us for the next #CAPA #GYNpath lecture! On July 19 (Sun) at 7 PM ET, Dr. Yujun Gan will present “Ovarian Serous Proliferation: From Benign to Malignant,” highlighting the morphologic spectrum and key points for differential diagnosis. #PathTwitter
We’re proud to launch CAPA Grand Rounds with an inaugural lecture by Dr. Syed Z. Ali from @JHUPath. Join us on Aug 13 (Thu), 12 PM ET, for “The Bethesda Thyroid Revolution: Impact, Challenges, and Future Directions.” Don’t miss this timely update on thyroid #CytoPath #PathTwitter
💡 FREE Registration!
🔗 Register here (or scan the QR code on the flyer):
us02web.zoom.us/webinar/regi…
A full weekend of learning with CAPA! 📚 Kick things off this Saturday (Jul 11, 7 PM ET) with our CAPA Trainee Committee Lecture Series featuring Drs. Xiaoying Liu and Qiong Gan on challenges in effusion and pancreas cytology. See you this weekend! #PathTwitter #Cytopath
















